Effects of cannabidiol on cognitive health in older adults with HIV
Neurocognitive implications of cannabidiol (CBD) while aging with HIV
This study is looking at how CBD might help older adults with HIV by checking if it can improve memory and reduce anxiety, especially as they deal with age-related brain changes and inflammation.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Florida International University NIH-funded |
| Lab location | 1 site (Miami, United States) |
| Project ID | NIH-10641920 on NIH RePORTER |
What this research studies
This research investigates how cannabidiol (CBD) may influence neurocognitive health in older adults living with HIV. It focuses on understanding the potential benefits and risks of CBD use in this population, particularly regarding age-related cognitive decline and inflammation associated with HIV. The study uses a mouse model to explore how CBD affects memory and anxiety in the context of HIV-induced neurocognitive deficits. By examining these effects, the research aims to provide insights that could inform treatment options for aging individuals with HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 21 and above who are living with HIV and experiencing cognitive challenges.
Not a fit: Patients who are not living with HIV or who are younger than 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for improving cognitive health in older adults living with HIV.
How similar studies have performed: While the specific effects of CBD on aging with HIV are not extensively studied, there is evidence suggesting that cannabinoids may have therapeutic potential in age-related cognitive decline, indicating a promising area of exploration.
Where this research is happening
Miami, United States
- Florida International University — Miami, United States (Active)
Researchers
- Principal investigator: Rodriguez, Myosotys — Florida International University
- Study coordinator: Rodriguez, Myosotys
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.